analyzeportfolio
Nasdaq · Healthcare

LAKELAND INDUSTRIES INC (LAKE)

As-reported financials and SEC filings for LAKELAND INDUSTRIES INC. The latest annual period is FY2026. The latest reported quarter is Q1 FY2027. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About LAKELAND INDUSTRIES INC

Lakeland Industries Inc, operating as Lakeland Fire + Safety, designs, manufactures, and sells safety products that protect workers, first responders, and communities in critical situations. Its product range includes firefighter protective apparel and accessories, high-end chemical protective suits, limited-use disposable clothing, and durable woven garments, serving markets such as chemical, energy, fire service, manufacturing, and utilities worldwide. The company also provides advanced decontamination, inspection, and repair services for firefighting garments through its acquired subsidiaries.

Snapshot

Revenue
$192.6M
Revenue growth (YoY)
15.2%
Net income
$-25.3M
Diluted EPS
$-2.63
Gross margin
32.9%
Operating margin
-8.1%
Net margin
-13.1%
FCF margin
-8.5%
ROE
-19.6%
net income / fiscal-year-end equity
P/E
trailing when available, otherwise FY EPS
Market cap
$117.9M
Long-term debt / equity
0.24×
non-current term debt only

Fundamentals are from SEC filings for FY2026, the latest annual period (ended January 31, 2026). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Lakeland Industries

  • Revenue grew 15.2% to $193M in FY2026, slower than the 34.1% the year before.
  • Operating margin is now a 8.1% loss in FY2026, from 13.6% in FY2022.
  • Most recent quarter Q1 FY2027: revenue $47M, up 1.4% from Q1 FY2026.
  • Free cash flow was negative $16M in FY2026.
  • Net loss widened to $25M in FY2026, from $18M in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Lakeland Industries’s fundamentals sit among the 558 Healthcare companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin32.9%
14th percentile of 282
Operating margin-8.1%
38th percentile of 399
Net margin-13.1%
33rd percentile of 418
FCF margin-8.5%
28th percentile of 372
Revenue growth (YoY)+15.2%
59th percentile of 538
ROE-19.6%
43rd percentile of 473
Long-term debt / equity0.24×
33rd percentile of 243
Short interest21.58d
98th percentile of 557

Lakeland Industries’s gross margin of 32.9% ranks in the 14th percentile of the 282 Healthcare companies reporting it.

No reported insider transactions (codes P/S) in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 4 quant / multi-strat books among the superinvestors we track; no conviction manager currently reports a position.

Conviction investors
0
+4 quant / multi-strat
Initiated / added
3
2 new, 1 added
Reduced / exited
1
1 trimmed, 0 exited
Combined position
$3.6M
reported long value
InvestorAs ofPosition valueSharesChange
Renaissance TechnologiesquantQ2 2026$2.0M182.8KReduced
Millennium ManagementquantQ2 2026$1.1M107.4KNew
Citadel AdvisorsquantQ2 2026$304,61228.5KNew
AQR Capital ManagementquantQ2 2026$158,94914.9KAdded

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
1.3M
settled 2026-08-14
Change vs prior
-4.0%
vs previous settlement
Days to cover
21.58
at avg daily volume
Avg daily volume
58.4K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-141.3M-4.0%21.58
2026-07-311.3M-5.6%21.54
2026-07-151.4M+8.0%17.35
2026-06-301.3M-3.7%5.74
2026-06-151.3M-12.1%5.09
2026-05-291.5M+3.4%13.45
2026-05-151.5M-3.7%12.61
2026-04-301.5M-1.1%12.78

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2026FY2025FY2024FY2023FY2022
Revenue$192.6M$167.2M$124.7M$112.8M$118.4M
Gross profit$63.3M$68.7M$51.2M$45.8M$50.9M
Operating income$-15.5M$-9.3M$6.0M$5.5M$16.0M
Net income$-25.3M$-18.1M$5.4M$1.9M$11.4M
Diluted EPS$-2.63$-2.43$0.72$0.24$1.41

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2026FY2025FY2024FY2023FY2022
Cash and equivalents$12.5M$17.5M$25.2M$24.6M$52.7M
Current assets$134.2M$136.5M$101.5M$105.6M$120.6M
Total assets$209.9M$212.5M$153.7M$142.9M$140.8M
Current liabilities$38.0M$34.9M$18.3M$18.6M$12.0M
Long-term debt$30.4M$16.4M
Total liabilities$80.8M$65.9M$30.3M$22.9M$15.7M
Total equity$129.1M$146.6M$123.5M$120.0M$125.1M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2026FY2025FY2024FY2023FY2022
Operating cash flow$-15.8M$-15.9M$10.9M$-5.5M$12.8M
Capital expenditure$671,000$1.5M$2.1M$2.0M$801,000
Free cash flow$-16.4M$-17.4M$8.8M$-7.4M$12.0M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q1 FY2027$47.4M1.4%$369,000$0.04
Q4 FY2026$45.8M-1.8%$-6.2M$-0.63
Q3 FY2026$47.6M4.0%$-16.0M$-1.64
Q2 FY2026$52.5M36.3%$766,000$0.08
Q1 FY2026$46.7M28.7%$-3.9M$-0.41
Q4 FY2025$46.6M49.2%$-18.4M$-2.71
Q3 FY2025$45.8M44.5%$86,000$0.01
Q2 FY2025$38.5M16.5%$-1.4M$-0.19

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNasdaq
SectorHealthcare
SIC industryOrthopedic, Prosthetic & Surgical Appliances & Supplies
Latest annual periodFY2026 (ended January 31, 2026)
Latest reported quarterQ1 FY2027 (ended April 30, 2026)
Oldest indexed filing2008
SEC CIK798081

Selected SEC filings

10-K/A2026-04-21
View on EDGAR →
10-K2026-04-16
View on EDGAR →
10-Q2026-06-09
View on EDGAR →
8-K2026-06-18
View on EDGAR →
8-K2026-06-09
View on EDGAR →
8-K2026-04-16
View on EDGAR →
8-K2026-03-30
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

Monitor LAKE

Get an alert when Lakeland Industries files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor LAKE free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.